The FDA Group
The FDA Group: Expert FDA Regulatory Consulting for Medical Devices
The FDA Group is a premier FDA regulatory consulting firm dedicated to empowering medical device companies. With seasoned experts, they specialize in strategic planning and execution for 510(k) submissions, de novo applications, and PMA processes across various device classes and panels. They provide tailored solutions accelerating product development and ensuring compliance through comprehensive support from initial classification assessments and QMS implementation to post-market vigilance and international regulatory strategies.
About
**Who they are**
The FDA Group is a regulatory consulting firm that provides expert guidance and support for medical device companies navigating the FDA regulatory landscape. They focus on helping clients achieve rapid clearance and market entry.
**Expertise & scope**
* **510(k) Strategy and Submission Services:** Assisting clients through the entire 510(k) process, from strategic planning to eSTAR submission, aiming for swift clearance.
* **Regulatory Submission Remediation:** Recovering stalled submissions by addressing deficiencies, strengthening data packages, and resolving issues like Complete Response Letters or clinical holds.
* **Auditing Services:** Offering GMP, GLP, GCP, and GCLP auditing services to ensure manufacturing excellence, laboratory data integrity, clinical trial integrity, and compliance with quality standards.
* **Staff Augmentation:** Providing senior regulatory strategists and leaders to guide product approvals, optimize regulatory approaches, and build regulatory organizations.
* **eSTAR Support:** Facilitating the use of eSTAR for submissions.
* **Regulatory Action Response:** Assisting with responses to regulatory actions and deficiencies.
**Reputation / proof points**
* Leverages former FDA investigators and industry professionals for auditing services.
* Employs a proprietary resource selection process for staff augmentation.
The FDA Group is a regulatory consulting firm that provides expert guidance and support for medical device companies navigating the FDA regulatory landscape. They focus on helping clients achieve rapid clearance and market entry.
**Expertise & scope**
* **510(k) Strategy and Submission Services:** Assisting clients through the entire 510(k) process, from strategic planning to eSTAR submission, aiming for swift clearance.
* **Regulatory Submission Remediation:** Recovering stalled submissions by addressing deficiencies, strengthening data packages, and resolving issues like Complete Response Letters or clinical holds.
* **Auditing Services:** Offering GMP, GLP, GCP, and GCLP auditing services to ensure manufacturing excellence, laboratory data integrity, clinical trial integrity, and compliance with quality standards.
* **Staff Augmentation:** Providing senior regulatory strategists and leaders to guide product approvals, optimize regulatory approaches, and build regulatory organizations.
* **eSTAR Support:** Facilitating the use of eSTAR for submissions.
* **Regulatory Action Response:** Assisting with responses to regulatory actions and deficiencies.
**Reputation / proof points**
* Leverages former FDA investigators and industry professionals for auditing services.
* Employs a proprietary resource selection process for staff augmentation.
Additional information
The FDA Group emphasizes a proactive approach to regulatory compliance, particularly in the face of evolving FDA staffing and review dynamics. They highlight the importance of a strong, well-prepared submission to navigate potential bottlenecks. For auditing services, they stress the value of auditors with direct experience from both industry and regulatory agencies, providing actionable insights beyond simple gap identification. Their remediation services are designed to salvage complex situations, requiring a deep understanding of both technical requirements and regulatory psychology to address fundamental gaps that simple amendments cannot fix.
Key Highlights
-
Offers comprehensive 510(k) strategy and submission services, including eSTAR preparation.
Source
“Navigate the evolving 510(k) landscape with confidence—from strategic planning through eSTAR submission—ensuring your device achieves rapid clearance”
-
Specializes in regulatory submission remediation for stalled applications, addressing deficiencies and roadblocks.
Source
“Salvage stalled submissions and overcome regulatory roadblocks with expert remediation that addresses deficiencies, strengthens data packages”
-
Provides auditing services across GMP, GLP, GCP, and GCLP standards, leveraging former FDA investigators.
Source
“Our GMP auditors bring decades of experience from both sides of the inspection table, understanding not just what regulations require”
-
Offers staff augmentation for regulatory strategy and leadership roles, providing seasoned RA leadership.
Source
“Access senior regulatory strategists and leaders who can guide your products through complex approval pathways”
Certifications & Trust Signals
-
Auditors include former FDA investigators.
Source
“Many have spent years as FDA investigators, learning firsthand what catches regulatory attention.”
-
Focuses on practical solutions aligned with business objectives.
Source
“provide actionable roadmaps for sustainable compliance that align with your business objectives.”
Buyer Snapshot
Best for
- Companies seeking expert guidance for FDA 510(k) submissions.
- Firms with stalled or deficient regulatory submissions requiring remediation.
- Organizations needing to ensure compliance through GMP, GLP, GCP, or GCLP audits.
- Businesses looking to augment their regulatory strategy and leadership teams.
How engagement typically works
- Collaborative, providing strategic planning and hands-on support.
- Remediation-focused, addressing specific submission deficiencies.
- Audit-driven, ensuring quality and compliance standards.
- Flexible staff augmentation for leadership roles.
Typical deliverables
- Strategic 510(k) plans and eSTAR submissions.
- Remediated submission packages.
- Comprehensive audit reports and CAPA recommendations.
- Interim or fractional regulatory leadership support.
Good to know
- Best when a strong, well-prepared submission is critical for timely clearance.
- Ideal for complex regulatory challenges requiring specialized expertise.
- Suitable for companies needing to quickly build or bolster their regulatory capabilities.
HQ:
US
Languages:
English
Timezones:
EST
Claim status:
Listed
Services & Capabilities
FDA 510(k) Submission Services
Services Offered:
510(k) Strategy & Authoring, 510(k) eSTAR Preparation, Pre-Sub / Q-Sub Preparation, FDA Meeting Support (Q-Sub / Type C), Labeling Review for Submission (510(k)/De Novo/PMA), Submission Project Management (end-to-end), 510(k) RTA Remediation / Refuse-to-Accept Fix, Predicate Research & Substantial Equivalence Strategy, Regulatory Pathway Assessment, PMA Strategy & Support, De Novo Strategy & Authoring
Pathways Supported:
Traditional 510(k), Special 510(k), Abbreviated 510(k), De Novo, PMA, Pre-Sub / Q-Sub
Device Types Supported:
Medical device
Supports Estar:
Yes
Supports Rta Remediation:
Yes
Supports Predicate Research:
Yes
Supports Labeling Review:
Yes
Provides Submission Project Management:
Yes
Ex FDA:
Yes
Engagement Models:
Contracted, Embedded, Fractional executive support, Interim leadership
